Cyclopharm Ltd (CYC)

Overview

Cyclopharm Limited, established in 1986, is a prominent entity engaged in manufacturing and distributing medical equipment and radiopharmaceuticals across the Asia Pacific, Europe, Canada, and other international markets. The company operates through its two main segments: Technegas and Molecular Imaging. By serving the nuclear medicine departments, Cyclopharm Limited has solidified its position, offering diagnostic solutions for pulmonary embolism, cancer, neurological disorders, and cardiac diseases. Headquartered in Kingsgrove, Australia, Cyclopharm continues to innovate in the medical imaging sector, catering to the needs of physicians and patients globally.

Products and Services

• Technegas Segment

This segment of Cyclopharm Limited focuses on providing diagnostic equipment and consumables specifically designed for the detection of pulmonary embolism. The offering includes a unique product line that physicians utilize in nuclear medicine for diagnosing this condition. Additionally, the Technegas segment plays a crucial role in distributing these products to the diagnostic imaging sector, thereby facilitating broader access to essential diagnostic solutions.

• Molecular Imaging Segment

Cyclopharm’s Molecular Imaging segment concentrates on the development and distribution of radiopharmaceuticals. These specialized products are employed by physicians in identifying and diagnosing various critical health conditions, including cancer, neurological disorders, and cardiac diseases. Through this segment, Cyclopharm provides indispensable tools that aid in the visualization and analysis of complex diseases, supporting clinicians in their efforts to deliver targeted and effective treatments.